SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-24-000397
Filing Date
2024-03-11
Accepted
2024-03-11 19:12:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2794
  Complete submission text file 0001972362-24-000397.txt   4456
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Subject) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36332 | Film No.: 24739722
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EVOKE PHARMA, INC. 505 LOMAS SANTA FE DRIVE SOLANA BEACH CA 92075
Business Address
Brady Todd C (Reporting) CIK: 0001579179 (see all company filings)

Type: 144